Amit Singhal to Tuberculosis, Pulmonary
This is a "connection" page, showing publications Amit Singhal has written about Tuberculosis, Pulmonary.
Connection Strength
0.533
-
Chang X, Li Z, Thai PVK, Ha DTM, Thuong NTT, Wee D, Subhan ASBM, Silcocks M, Chee CBE, Nhu NTQ, Heng CK, Teo YY, Singhal A, Oehlers SH, Yuan JM, Koh WP, Caws M, Khor CC, Dorajoo R, Dunstan SJ. Genome-wide association study reveals a novel tuberculosis susceptibility locus in multiple East Asian and European populations. Genome Med. 2026 May 27; 18(1).
Score: 0.219
-
Miow QH, Vallejo AF, Wang Y, Hong JM, Bai C, Teo FS, Wang AD, Loh HR, Tan TZ, Ding Y, She HW, Gan SH, Paton NI, Lum J, Tay A, Chee CB, Tambyah PA, Polak ME, Wang YT, Singhal A, Elkington PT, Friedland JS, Ong CW. Doxycycline host-directed therapy in human pulmonary tuberculosis. J Clin Invest. 2021 08 02; 131(15).
Score: 0.157
-
Pisu D, Huang L, Narang V, Theriault M, L?-Bury G, Lee B, Lakudzala AE, Mzinza DT, Mhango DV, Mitini-Nkhoma SC, Jambo KC, Singhal A, Mwandumba HC, Russell DG. Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung. J Exp Med. 2021 09 06; 218(9).
Score: 0.157